Performance

1 day-4.65%
Current month-5.96%
1 month-25.18%
3 months+23.35%
6 months-18.49%
Current year-8.89%
1 year-51.54%
3 years-84.47%
5 years-97.18%

Volumes

markets
Daily volume
505,055
Estimated daily volume
505,055
Avg. Volume 20 sessions
1,886,814
Daily volume ratio
0.27
Avg. Volume 20 sessions SEK
386,796.87
Avg. Volume 20 sessions USD
39,771.23
Record volume 1
56,226,840
Record volume 2
50,102,210
Record volume 3
20,374,870
Capital turnover ratio
0.03
Float rotation
0.04

Basic data

Market Cap (SEK)
13,637,773
Market Cap (USD)
1,403,921
Number of employees
2
Sales / Employee ()
0
Sales / Employee (USD)
0
Free-Float
78.48 %
Free-Float capitalization (SEK)
10,703,427
Free-Float capitalization (USD)
1,101,849
Average Daily Capital Traded
2.84%

Indicators

Moving average 5 days
0.22
Moving average 20 days
0.24
Moving average 50 days
0.17
Moving average 100 days
0.18
Price spread / (MMA5)
+7.32%
Price spread / (MMA20)
+17.07%
Price spread / (MMA50)
-17.07%
Price spread / (MMA100)
-12.20%
RSI 9 days
45.33
RSI 14 days
49.75

Change 5-day change 1-year change 3-year change Capi.($)
-4.65%0.00%-51.54%-84.47% 1.4M
+0.33%+1.37%+63.66%+126.38% 55.63B
+0.82%+15.05%+79.52%+85.53% 52.25B
+1.36%+0.36%-14.52%-13.83% 23.07B
-1.04%+7.91%+3.91%+417.68% 22.41B
-0.18%+7.20%+31.37%-13.62% 17.32B
-1.10%+4.00%+29.97%-33.36% 15.94B
+2.89%+5.51%+25.42%+186.30% 13.77B
-3.35%+8.96%+134.32%+289.59% 13.47B
+1.31%+0.53%+27.83% - 12.43B
Average -0.36%+4.78%+32.99%+106.69% 22.63B
Weighted average by Cap. +0.26%+5.13%+48.50%+122.68%

Historical Quotes: Stayble Therapeutics AB

DateOpeningHighLowCloseVolumeChange
Chart Stayble Therapeutics AB

Course Extremes

1 month 0.2
Extreme 0.1955
0.36
Current year 0.03
Extreme 0.0274
0.65
1 year 0.03
Extreme 0.0274
0.65
3 years 0.03
Extreme 0.0274
6.42
5 years 0.03
Extreme 0.0274
9.2
10 years 0.03
Extreme 0.0274
17.5

Monthly variations

Annual variations

2026-8.89%
2025-55.88%
2024+68.32%
2023-92.43%
2022-36.71%
2021-35.90%
2020+2.18%
  1. Stock Market
  2. Stocks
  3. STABL Stock
  4. Quotes Stayble Therapeutics AB